References
Hosokawa I, Allard MA, Gelli M, et al. Long-term survival benefit and potential for cure after R1 resection for colorectal liver metastases. Ann Surg Oncol. 2016; 23:1897–1905.
Cucchetti A, Ferrero A, Cescon M, et al. Cure model survival analysis after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2014; 19:1602–1608.
Oba M, Hasegawa K, Matsuyama Y, et al. Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure. Ann Surg Oncol. 2014; 21:1817–1824.
Adam R, Wicherts DA, de Haas RJ, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol. 2009; 27:1829–1835.
Disclosures
Isamu Hosokawa, Marc-Antoine Allard, Gabriella Pittau, Masaru Miyazaki, and René Adam declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hosokawa, I., Allard, MA., Pittau, G. et al. Comment on “Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases”: A Reply. Ann Surg Oncol 24 (Suppl 3), 656–657 (2017). https://doi.org/10.1245/s10434-017-6123-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-017-6123-9